Immunology News and Research

Latest Immunology News and Research

Advair reduces asthma-related hospitalization and emergency department visits

Advair Diskus (fluticasone propionate and salmeterol inhalation powder) was associated with fewer asthma-related hospitalizations and emergency department (ED) visits in pediatric patients when compared to the use of inhaled corticosteroids (ICS) alone, and use of Advair by pediatric and adult patients through the summer was associated with fewer hospitalizations and ED visits in the fall.

17 Mar 2008

New chemical can kill latent tuberculosis bacteria

Success in the laboratory suggests that a new compound can point the way to preventing active tuberculosis in people infected with the latent form of the bacterium, says a team led by researchers at Weill Cornell Medical College in New York City.

17 Mar 2008

How diabetes drives atherosclerosis

Researchers have discovered how diabetes, by driving inflammation and slowing blood flow, dramatically accelerates atherosclerosis, according to research to be published in the March 14 edition of the journal Circulation Research. Experts once believed that atherosclerosis, or hardening of the arteries, developed when too much cholesterol clogged arteries with fatty deposits called plaques.

14 Mar 2008

Finding in mice could help prevent common complications of kidney damage

Kidney damage often sets off a slew of complications in patients, spreading organ failure like wildfire throughout their bodies.

14 Mar 2008

Researchers find cause of severe allergic reaction to cetuximab

Clinicians have been perplexed by the fact that some patients given the drug cetuximab - an immune-based therapy commonly used to treat persons diagnosed with head and neck cancer, or colon cancer - have a severe and rapid adverse reaction to the drug.

13 Mar 2008

Thermo Fisher Scientific creates breakthrough gene-silencing tool

Thermo Fisher Scientific Inc. has developed a breakthrough gene-silencing tool that greatly simplifies RNA- interference (RNAi) technology and eliminates barriers associated with previous cellular delivery methods.

From Thermo Fisher Scientific Inc. 12 Mar 2008

Allergy testing is essential in the effective management of patients with allergic conditions

When combined with a detailed medical history, it can identify the causes of allergy symptoms and provide the basis for avoidance, environmental control and immunotherapy.

11 Mar 2008

London School of Hygiene and Tropical Medicine receives new Gates funding to fight disease

The London School of Hygiene & Tropical Medicine (LSHTM) has been awarded grant funding totalling $46.4 million from the Bill and Melinda Gates Foundation (BMGF) and $12.7 million from other partners, to help find new and effective ways of treating and preventing malaria, tuberculosis (TB) and HIV/AIDS.

10 Mar 2008

Aromatherapy and pain relief?

One of the most comprehensive investigations done to date on aromatherapy failed to show any improvement in either immune status, wound healing or pain control among people exposed to two often-touted scents.

4 Mar 2008

New way to develop tumor vaccines

Researchers at the University of Southern California (USC) have uncovered a new way to develop more effective tumor vaccines by turning off the suppression function of regulatory T cells.

3 Mar 2008

Indoor allergen exposure a great importance in relation to asthma

Results from a new national survey demonstrate that elevated allergen levels in the home are associated with asthma symptoms in allergic individuals.

3 Mar 2008

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

A new international study finds that introducing an increased intensity of chemotherapy in children with severe Langerhans cell histiocytosis (LCH) can reduce the mortality rate for this disorder by as much as 20 percent when the patient demonstrates a rapid response to such treatment.

3 Mar 2008

HIV blocking gene found

A team of researchers at the University of Alberta, including a scientist at the University of Pennsylvania, have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS.

1 Mar 2008

Potential target to treat deadly bloodstream infections

Researchers at the University of Illinois at Chicago have discovered a possible target to treat bloodstream bacterial infections.

28 Feb 2008

Springer launches 18,000 searchable online protocols in life sciences and biomedicine

Springer Science+Business Media (www.springer.com) has announced the release of Springer Protocols, a protocol database of more than 18,000 searchable online protocols in life sciences and biomedicine.

28 Feb 2008

Scientists devise approach that stops HIV at earliest stage of infection

Their study, which appears this week in the online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), may re-energize attempts to create a preventive/therapeutic vaccine against HIV, say the authors.

28 Feb 2008

Nasal vaccine for smallpox protects animals against 77 times the potentially lethal dose of smallpox

Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially lethal dose of smallpox, and without the safety risks of current vaccines for smallpox.

27 Feb 2008

Nanoemulsion vaccines show increasing promise

A novel technique for vaccinating against a variety of infectious diseases - using an oil-based emulsion placed in the nose, rather than needles - has proved able to produce a strong immune response against smallpox and HIV in two new studies.

27 Feb 2008

New proof-of-principle findings that thymic involution can be reversed in humans

Scientists at the Gladstone Institute of Virology and Immunology (GIVI) and the University of California, San Francisco (UCSF) have found that therapy can be used to stimulate the production of vital immune cells, called "T- cells," in adults with HIV infection.

21 Feb 2008

Mutation in TDP-43 gene may play role in common dementia

Scientists at Washington University School of Medicine in St. Louis have linked a mutation in a gene known as TDP-43 to an inherited form of amyotrophic lateral sclerosis (ALS), the neurodegenerative condition often called Lou Gehrig's disease.

21 Feb 2008

Immunology News and Research

Latest Immunology News and Research

Advair reduces asthma-related hospitalization and emergency department visits

New chemical can kill latent tuberculosis bacteria

How diabetes drives atherosclerosis

Finding in mice could help prevent common complications of kidney damage

Researchers find cause of severe allergic reaction to cetuximab

Thermo Fisher Scientific creates breakthrough gene-silencing tool

Allergy testing is essential in the effective management of patients with allergic conditions

London School of Hygiene and Tropical Medicine receives new Gates funding to fight disease

Aromatherapy and pain relief?

New way to develop tumor vaccines

Indoor allergen exposure a great importance in relation to asthma

Clinical trial shows reduction in mortality for children with severe Langerhans cell histiocytosis

HIV blocking gene found

Potential target to treat deadly bloodstream infections

Springer launches 18,000 searchable online protocols in life sciences and biomedicine

Scientists devise approach that stops HIV at earliest stage of infection

Nasal vaccine for smallpox protects animals against 77 times the potentially lethal dose of smallpox

Nanoemulsion vaccines show increasing promise

New proof-of-principle findings that thymic involution can be reversed in humans

Mutation in TDP-43 gene may play role in common dementia

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog